Psychometric properties of the Danish Hospital Anxiety and Depression Scale in patients with cardiac disease:results from the DenHeart survey by Christensen, Anne Vinggaard et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Psychometric properties of the Danish Hospital Anxiety and Depression Scale in
patients with cardiac disease
results from the DenHeart survey
Christensen, Anne Vinggaard; Dixon, Jane K.; Juel, Knud; Ekholm, Ola; Rasmussen, Trine
Bernholdt; Borregaard, Britt; Mols, Rikke Elmose; Thrysøe, Lars; Thorup, Charlotte Brun;
Berg, Selina Kikkenborg
Published in:
Health and Quality of Life Outcomes
DOI:
10.1186/s12955-019-1264-0
Publication date:
2020
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Christensen, A. V., Dixon, J. K., Juel, K., Ekholm, O., Rasmussen, T. B., Borregaard, B., ... Berg, S. K. (2020).
Psychometric properties of the Danish Hospital Anxiety and Depression Scale in patients with cardiac disease:
results from the DenHeart survey. Health and Quality of Life Outcomes, 18(1), [9].
https://doi.org/10.1186/s12955-019-1264-0
Download date: 10. Sep. 2020
RESEARCH Open Access
Psychometric properties of the Danish
Hospital Anxiety and Depression Scale in
patients with cardiac disease: results from
the DenHeart survey
Anne Vinggaard Christensen1* , Jane K. Dixon2, Knud Juel3, Ola Ekholm3, Trine Bernholdt Rasmussen4,
Britt Borregaard5, Rikke Elmose Mols6, Lars Thrysøe7, Charlotte Brun Thorup8 and Selina Kikkenborg Berg1,3,9
Abstract
Background: Anxiety and depression symptoms are common among cardiac patients. The Hospital Anxiety and
Depression Scale (HADS) is frequently used to measure symptoms of anxiety and depression; however, no study on
the validity and reliability of the scale in Danish cardiac patients has been done. The aim, therefore, was to evaluate
the psychometric properties of HADS in a large sample of Danish patients with the four most common cardiac
diagnoses: ischemic heart disease, arrhythmias, heart failure and heart valve disease.
Methods: The DenHeart study was designed as a national cross-sectional survey including the HADS, SF-12 and
HeartQoL and combined with data from national registers. Psychometric evaluation included analyses of floor and
ceiling effects, structural validity using both exploratory and confirmatory factor analysis and hypotheses testing of
convergent and divergent validity by relating the HADS scores to the SF-12 and HeartQoL. Internal consistency
reliability was evaluated by Cronbach’s alpha, and differential item functioning by gender was examined using
ordinal logistic regression.
Results: A total of 12,806 patients (response rate 51%) answered the HADS. Exploratory factor analysis supported
the original two-factor structure of the HADS, while confirmatory factor analysis supported a three-factor structure
consisting of the original depression subscale and two anxiety subscales as suggested in a previous study. There
were floor effects on all items and ceiling effect on item 8. The hypotheses regarding convergent validity were
confirmed but those regarding divergent validity for HADS-D were not. Internal consistency was good with a
Cronbach’s alpha of 0.87 for HADS-A and 0.82 for HADS-D. There were no indications of noticeable differential item
functioning by gender for any items.
Conclusions: The present study supported the evidence of convergent validity and high internal consistency for
both HADS outcomes in a large sample of Danish patients with cardiac disease. There are, however, conflicting
results regarding the factor structure of the scale consistent with previous research.
Trial registration: ClinicalTrials.gov: NCT01926145.
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Background
Anxiety and depression symptoms are common among
cardiac patients with prevalence rates of up to 30 and
20%, respectively, at hospital discharge and up to three
months after hospitalization. This reflects the possible
severity of the physical illness on other aspects of health
[1, 2]. Previous studies have shown that anxiety and
depression symptoms can predict future morbidity and
mortality among cardiac patients [3, 4] underlining the
importance of identifying these symptoms in order to
initiate interventions to reduce them. A prerequisite for
this is having a valid instrument to identify the
symptoms.
The Hospital Anxiety and Depression Scale (HADS)
was developed for patients with somatic illness admitted
to the hospital [5] and is often used as a self-rating scale
to screen for anxiety and depression symptoms across a
wide range of patient and general populations. The scale
includes two subscales, HADS-A and HADS-D measur-
ing anxiety and depression symptoms, respectively. The
scale is focused on the psychic symptoms of mood disor-
ders, leaving out physical symptoms that can be con-
fused with physical illness [5]. This is an advantage in
cardiac populations where symptoms such as palpita-
tions or dizziness might be related to the underlying
cardiac disease and not a potential mood disorder.
HADS has been extensively tested for validity and
reliability in English and other language versions, with
satisfactory results across different patient populations,
e.g. cardiac disease, cancer, psychological illness and in
general populations [6–8]. Looking at previous valid-
ation studies of HADS in cardiac populations, however,
there are differing results regarding the factor structure
of the scale, Table 1. The originally proposed two-factor
structure is confirmed in six studies [9–14], but eight
studies find different versions of a three-factor structure
to have the best fit depending on the analytic method
used [12, 13, 15–20]. By contrast, one study finds a one-
factor structure to have the best fit [21].
Differential item functioning (DIF) is a form of meas-
urement error at item level by which patients from dif-
ferent groups with the same level of a construct being
measured do not have the same scores. The presence of
DIF by gender has been examined for HADS, but the
results are not consistent [22–24].
HADS has been translated into Danish and is fre-
quently used in clinical research but the psychometric
properties of the Danish version have not been evalu-
ated. Even though the scale has been found to be valid
and reliable in previous studies, this is no assurance of
equivalent validity when used in a different language,
culture or context. Therefore, the aim of the current
study was to evaluate the psychometric properties of the
Danish HADS in a large population of patients with the
most common cardiac diagnoses: ischemic heart disease,
arrhythmias, heart failure and heart valve diseases.
Methods
Data collection and sample
Data was collected as part of the DenHeart study. The
design and methods have been described in the pre-
published protocol [25]. The DenHeart study was de-
signed as a national cross-sectional survey combined
with data from national registers at baseline and one
year follow-up. Over a period of one year (April 2013–
April 2014) all patients discharged or transferred from
one of five national heart centers were asked to fill out a
questionnaire at hospital discharge. Excluded were pa-
tients under the age of 18, patients without a Danish
civil registration number, patients who did not under-
stand Danish and patients who were unconscious when
transferred from a heart center.
Based on their discharge diagnosis from the Danish
National Patient Register [26], patients were divided into
diagnostic sub-groups [2]. Included in the current ana-
lyses are patients with ischemic heart disease, arrhyth-
mias, heart failure and heart valve diseases.
Furthermore, co-morbidity characteristics were col-
lected from the Danish National Patient Register [26].
The Tu co-morbidity index was calculated including
congestive heart failure, cardiogenic shock, arrhythmia,
pulmonary oedema, malignancy, diabetes, cerebrovascu-
lar disease, acute/chronic renal failure and chronic ob-
structive pulmonary disease – all calculated ten years
back [27].
Information on demographic characteristics were
collected from the Civil Registration System [28] and the
Danish Education Register [29].
The HADS questionnaire
The HADS is a 14 item questionnaire originally devel-
oped to measure anxiety and depression symptoms in
patients with somatic disease [5]. The instrument offers
two subscales, HADS-A and HADS-D, each consisting
of seven items and measuring anxiety and depression
symptoms, respectively. HADS-A is focused on symp-
toms relating to generalized anxiety and HADS-D on
symptoms relating to anhedonia, a central aspect of
depression [30]. Each item is scored on a scale of 0–3
with each subscale score ranging from 0 to 21. Eight
items are reverse scored with higher scores indicating a
better response. These are reversed when summing the
two subscales. The recommended cut-off values are 8–
10 for possible presence of a mood disorder and ≥ 11
for probable presence of a mood disorder [5]. It has
previously been found that among cardiac patients the
minimal clinically important difference on the HADS is
1.7 points [31].
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Table 1 Previous validations of HADS in patients with cardiac disease
Cronbach’s alpha
Reference Language Population Analytic
methods
Number
of factors
Sub scale content HADS-A HADS-D Correlation
between
sub scales
Ayis et al.
2018 [9]
English Stroke (n = 1443) ML
PCA
CFA
(and IRT)
2 Anxiety:
1,3,5,7,9,11,13
Depression: 2,4,6,8,10,12,14
Kaur et al.
2015 [15]
Malaysian Coronary artery
disease (n = 189)
PCA
CFA
3 Anxiety:
1,3,5,7,9,11,13
Anhedonia:
2,4,6,14
Psychomotor retardation: 8,
10,12
0.89 0.69
Anhedonia: 0.70
Psychomotor
retardation: 0.51
Anhedonia –
psychomotor
retardation:
0.35
Anhedonia –
anxiety:
0.47
Psychomotor
retardation –
anxiety:
0.39
De Smedt
et al. 2013 [10]
22
European
countries
CABG, PCI, AMI,
myocardial
ischemia
(n = 8745)
CFA 2 Anxiety: 1,3,5,7,9,11,13
Depression: 2,4,6,8,10,12,14
0.82 0.74 0.60
Cosco et al.
2012 [21]
English Cardiovascular
disease (n = 893)
MSA 1 1,2,3,4,5,6,7,9,10,11,12,13
Emons et al.
2012 [16]
Dutch Cardiac patients
(n = 534)
MSA
EFA CFA
3 Anxiety: 1,3,5,9,13
Depression: 2,4,6,8,10,12
Restlessness: 7,11,14
Depression –
restlessness:
0.62
Restlessness
– anxiety:
0.68
Depression
– anxiety:
0.66
Kendel et al.
2010 [22]
German CABG
(n = 1271)
Rasch
(HADS-D
only)
Depression: 2,4,6,12
Hunt-Shanks
et al. 2010 [17]
English Cardiac patients
(n = 801)
CFA 3 Negative affect: 1,5,7,11
Autonomic anxiety: 3,9,13
Depression: 2,4,6,8,10,12,14
Martin et al.
2008 [18]
German
Chinese
English
Coronary heart
disease
(n = 1793)
MGCFA 3 Antonomic anxiety:
3,9,13 Negative affectivity: 1,
5,7,11Anhedonic depression:
2,4,6,8,10,12,14
Pais-Ribeiro
et al. 2007 [11]
Portuguese Mixed patients
incl. Coronary
heart disease
(n = 1322)
EFA
CFA
2 Anxiety:
1,3,5,7,9,11,13
Depression: 2,4,6,8,10,12,14
0.76 0.81 0.58
Wang et al.
2006 [12]
Chinese Coronary heart
disease (n = 154)
CFA 2 or 3 2: Anxiety: 1,3,5,9,11
Depression: 2,4,6,7,8,10,12,14
3: Antonomic anxiety:
3,9,13
Negative affectivity: 1,5,7,11
Anhedonic depression: 2,4,6,
8,10,12,14
Barth and
Martin 2005 [13]
German Coronary heart
disease (n = 1320)
EFA
CFA
EFA: 2
CFA: 3
EFA:
Anxiety:
1,3,5,7,9,11,13
Depression: 2,4,6,8,10,12,14
CFA:
Psychomotor agitation: 1,7,
11
Psychic anxiety:
0.82
(between
HADS-A and
HADS-D)
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The Danish version of HADS has been frequently used
for research purposes, both in observational studies and
randomized controlled trials, as well as for screening
purposes in clinical practice [2, 3, 32–36].
The translation of the HADS from English into Danish
was evaluated by five independent assessors who were
fluent in both English and Danish. For each item the
equivalence of the translation was evaluated on a scale
from 1 to 4, with higher numbers indicating stronger
equivalence. The Translation Validity Index (TVI) was
calculated as the proportion of assessments rated posi-
tively with score of 3 or 4 [37].
Other instruments
The Short-Form 12 health survey (SF-12) is a brief, gen-
eric measure of health-related quality of life that gener-
ates both a physical (PCS) and a mental component
score (MCS). Higher scores indicate better health status
[16]. The SF-12 has been validated in a population of pa-
tients with coronary heart disease from 22 European
countries with satisfactory results for construct validity
and a Cronbach’s alpha of 0.87 for PCS and 0.84 for
MCS, respectively, indicating high internal consistency
reliability [10]. HeartQoL is a disease-specific question-
naire that measures quality of life in cardiac patients and
produces a global score and two subscales: a physical
and an emotional scale ranging from 0 to 3 with higher
scores indicating better quality of life status [18–20].
The instrument has been validated in a large sample of
coronary patients with results confirming both discrim-
inative and convergent validity and high reliability with a
Cronbach’s alpha of 0.87 for the emotional subscale and
0.91 for the physical one [38].
Furthermore, two single items on anxiety and depres-
sion allowed patients to rate anxiety and depression on a
10-point Likert scale.
Psychometric properties of HADS
The following psychometric properties of the HADS
were evaluated.
Floor and ceiling effects occur if more than 15% of the
patients select the lowest or highest possible score on an
item. Floor and ceiling effects can be an indication that
extreme items are missing in either end of the scale,
which can possibly limit its validity [39, 40].
Construct validity is defined as the degree to which an
instrument measures what it is intended to measure. It
is evaluated by testing hypotheses about an instrument –
for example, relationships between parts of an instru-
ment, relationships with scores of other instruments or
differences between relevant groups [41]. An aspect of
construct validity is structural validity, which is the
degree to which the sub-scale scores of an instrument
are an adequate reflection of the dimensions of the
construct to be measured [41]. Structural validity was
evaluated using exploratory factor analysis (EFA) and
confirmatory factor analyses (CFA). CFA was conducted
for the original two-factor structure suggested by
Zigmond and Snaith [5], and also for four three-factor
models [15, 42–44] and one one-factor model [21] found
in previous studies including cardiac patients.
Construct validity was also examined through hypoth-
eses testing by looking at HADS scores in relation to the
Table 1 Previous validations of HADS in patients with cardiac disease (Continued)
Cronbach’s alpha
Reference Language Population Analytic
methods
Number
of factors
Sub scale content HADS-A HADS-D Correlation
between
sub scales
3,5,9,13
Depression: 2,4,6,8,10,12,14
Martin et al.
2004 [52]
Chinese Acute coronary
syndrome
(n = 138)
CFA 3 Different models apply 0.79 0.55
Martin et al.
2003 [19]
English MI
(n = 335)
CFA 3 Anhedonia: 2,4,6,8,10,12,14
Psychic anxiety:
3,5,9,13
Psychomotor agitation: 1,7,
11
0.83–0.86
(3 timepoints)
0.76–0.80
(3 timepoints)
Roberts et al.
2001 [14]
English Female cardiac
patients (n = 167)
CFA 2 Anxiety:
1,3,5,7,9,11,13
Depression: 2,4,6,8,10,12,14
0.85 0.80 0.60
Martin and
Thompson
2000 [20]
English MI
(n = 194)
EFA 3 1: 2,4,6,7,8,10,12,14
2: 3,9,13
3: 1,5,11
0.76 0.72 0.54
ML maximum likelihood; PCF principal component analysis; CFA confirmatory factor analysis; IRT item response theory; MSA Mokken scale analysis; EFA exploratory
factor analysis; CABG coronary artery bypass graft; PCI percutaneous coronary intervention; AMI acute myocardial infarction; MGCFA meta group confirmatory
factor analysis; MI myocardial infarction
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MCS on SF-12, the emotional subscale of HeartQoL and
a single item on anxiety and a single item on depression
(convergent construct validity), and in relation to the
PCS and physical subscale of HeartQoL (divergent con-
struct validity).
We hypothesized high correlations (r > 0.60) between
both HADS-A and HADS-D and the MCS score and the
HeartQoL emotional score and high correlations be-
tween HADS-A and a single item measuring anxiety,
and between HADS-D and a single item measuring de-
pression. Furthermore, we hypothesized low correlations
(r < 0.30) between HADS-A and HADS-D and PCS and
HeartQoL physical as these measures were not supposed
to be related to the HADS subscales.
Internal consistency reliability is an indicator of the
extent to which the items of an instrument are internally
correlated and therefore measure the same construct.
This can be evaluated by calculating Cronbach’s alpha.
A Cronbach’s alpha of between 0.70 and 0.95 is an indi-
cation of good internal consistency [40].
DIF is a form of measurement invariance at item
level. DIF means that there are items for which patients
from different groups with the same level of the con-
struct being measured do not have the same scores.
This can indicate that the item measures different
things in the different groups. DIF can be uniform or
non-uniform depending on whether the differences are
present for all values of the scale or just for some values
of the scale [45].
Data analyses
Demographic and clinical characteristics are presented
as frequencies or means with standard deviations (SD).
Item score distributions are presented as means with
SD, frequencies for each response category and missing
data. Histograms and the Kolmogorov-Smirnov test were
used to determine whether item scores deviated from
the normal distribution.
Exploratory factor analysis was conducted using prin-
cipal axis extraction based on eigenvalues greater than 1.
Oblimin rotation was applied with a cut-off point of 0.30
as designating loading on a factor.
Confirmatory analyses were conducted with the
weighted least squared means and variance (WLSMV)
estimator. A Root Mean Square Error of Approximation
(RMSEA) estimate below 0.06 along with Comparative
Fit Index (CFI) and Tucker Lewis Index (TLI) estimates
above 0.95 indicated a good model fit [46].
Both the EFA and the CFA were conducted on the
total population. Extensive previous literature exists that
provide suggestions for models to be tested in the CFA.
Spearman’s rank-order correlations were used to de-
termine convergent and divergent validity as data were
not normally distributed. Convergent validity between
HADS, SF-12 and HeartQoL subscales was examined by
stratifying mean scores of MCS, PCS, and HeartQoL
emotional and HeartQoL physical by HADS-A and
HADS-D scores above and below 8.
Internal consistency was evaluated by calculating
Cronbach’s alpha for subscales and also by corrected
item-total correlations.
DIF was examined using multivariate ordinal logistic
regression with items as the dependent variable and
gender and total score (HADS-A or HADS-D depend-
ing on the item) as the independent variables. Because
the proportional odds assumption was not fulfilled a
partial proportional odds model was used. DIF was
evaluated by different criteria. Uniform DIF can be con-
sidered if the odds ratio (OR) for gender is statistically
significantly different from 1 [45]. Interactions between
gender and total score were included to evaluate pos-
sible non-uniform DIF. A statistically significant inter-
action can be an indication of non-uniform DIF [45].
Because of the large sample size and the risk of finding
statistically significant results with no or very little clin-
ical meaning, DIF was also evaluated by Nagelkerke’s
R.2 A difference in R2 of more than 0.03 between
models was an indication of noticeable DIF (both uni-
form and non-uniform) [45].
Only patients with complete responses to the HADS
were included in the analyses.
Analyses were conducted using SAS version 9.4, IBM
SPSS version 25 and Mplus version 7.4.
Results
Demographic and clinical profile
Out of 25,241 eligible patients, 12,806 had complete re-
sponses to the HADS questionnaire giving a response
rate of 51%. Demographic and clinical characteristics are
presented in Table 2.
Item score statistics and translation validity index
The item score statistics are presented in Table 3. Item
8 showed markedly different scores compared to the rest
of the items, with more patients using high response cat-
egories, Table 3. There were floor effects on all items
and a ceiling effect on item 8, Table 3.
Of the 14 items, 12 had an TVI of 100%, and two
(items 3 and 11) had TVI of 60% (both of these were a
part of HADS-A. The TVI for the total scale was 94%,
Additional file 1: Table S1.
Factor structure
The results from the EFA indicate that the original two-
factor structure of the HADS seems to fit in this cardiac
population. However, item 7 showed almost the same
loading on each subscale, Table 4. The correlation be-
tween HADS-A and HADS-D was 0.66.
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The CFA indicated that the three-factor structure sug-
gested by Friedman et al. [44] showed the best fit for the
models tested, Table 5. The diagram from the CFA of
the three-factor structure suggested by Friedman et al.
[44] is presented in Fig. 1.
Convergent and divergent validity
Looking at MCS, PCS, HeartQoL emotional and Heart-
QoL physical scores in relation to HADS scores, patients
with scores below 8 on both HADS-A or HADS-D had
high scores on MCS and HeartQoL emotional. Con-
versely, patients with HADS-A and HADS-D scores
above 8 have the lowest scores. The same pattern is
found in PCS and HeartQoL physical scores, Table 6.
Correlations between HADS-A and MCS and HeartQoL
emotional were 0.67 and 0.75, respectively. Correlations
between HADS-D and MCS and HeartQoL emotional
were 0.66 and 0.63, respectively. The correlation between
HADS-A and the single item on anxiety was 0.68 and be-
tween HADS-D and the single item on depression it was
0.59. This confirmed the stated hypotheses about conver-
gent validity. However, the two single items were highly
correlated (0.76).
Correlations between HADS-A and PCS and Heart-
QoL physical were 0.25 and 0.35, respectively. Correla-
tions between HADS-D and PCS and HeartQoL physical
were 0.50 and 0.55, respectively. This did not confirm
the hypotheses on divergent validity for HADS-D.
Internal consistency
For HADS-A mean inter-item correlation was 0.50
(range 0.35–0.61) and Cronbach’s alpha was 0.87. The
corrected item-total correlations ranged from 0.52 to
0.71. Cronbach’s alpha would not be improved by the
deletion of any item.
For HADS-D mean inter-item correlation was 0.41
(range 0.24–0.58). Cronbach’s alpha was 0.82. The cor-
rected item-total correlations ranged from 0.44 to 0.67.
Cronbach’s alpha would not be improved by the deletion
of any item.
For all HADS items the mean inter-item correlation
was 0.40 (range 0.24–0.61).
Looking at the three-factor structure, the Cronbach’s
alpha for the psychomotor agitation subscale was 0.74
and 0.83 for the psychic anxiety subscale. The HADS-D
subscale was unchanged with a Cronbach’s alpha of
0.82. Cronbach’s alpha would not be improved by the
deletion of any item.
Differential item functioning
There were indications of DIF for item 3, 4 and 13
where women were more likely to have high item scores
compared to men and for items 11 and 14 where men
were more likely to have high item scores compared to
women. There were significant interactions between
item and subscale for items 1, 2, 5, 7, 8, 9 and 12, which
is an indication of non-uniform DIF. However, in ana-
lysis using Nagelkerke’s R2 there was no noticeable DIF
for any item, Table 7.
Discussion
In the present study the psychometric properties of the
HADS in a large sample of Danish cardiac patients were
evaluated. Floor effects were found on all items and ceiling
effect on item 8. The original two-factor structure of the
scale was confirmed in EFA, but CFA indicated a three-
factor structure. The hypotheses proposed were supported
for both subscales, providing evidence for convergent
validity. However, for HADS-D the hypotheses proposed
for divergent validity were not supported. Thus, divergent
validity is not indicated. Internal consistency was good for
both HADS-A and HADS-D.
Table 2 Demographic and clinical characteristics
n 12,806
Male, n (%) 8953 (69.9)
Age, mean (SD) 65.1 (12.1)
Marital status (n,%)
Married
Divorced
Widowed
Unmarried
8307 (64.9)
1728 (13.5)
1533 (12.0)
1238 (9.6)
Educational level (n,%)
Basic school
Upper secondary or vocational school
Higher education
Missing
3903 (30.5)
5595 (43.7)
3018 (23.5)
290 (2.3)
Cardiac diagnosis (n,%)
Ischemic heart disease
Arrhythmias
Heart failure
Heart valve diseases
6832 (53.3)
4121 (32.2)
917 (7.2)
936 (7.3)
Co-morbidity (n,%)
Hypertension 4424 (34.6)
Ventricular arrhythmia 589 (4.6)
Ischemic heart disease 5544 (43.3)
Myocardial infarction 2408 (18.8)
Diabetes 1257 (9.8)
Heart failure 2210 (17.3)
Renal disease 426 (3.3)
Chronic obstructive pulmonary disease 837 (6.5)
Tu comorbidity score (n,%)
0 5271 (41.2)
1 4378 (34.2)
2 2062 (16.1)
≥3 1095 (8.5)
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The factor analyses indicate that the factor structure
of the HADS is not completely clear. The EFA con-
firmed the original two-factor structure suggested by
Zigmond and Snaith [5], but the CFA showed that the
three-factor structure as found by Friedman et al. [44] in
a French sample of patients suffering from major depres-
sion had the best model fit. The same result was found
by Barth and Martin in a German coronary heart disease
population [13]. Several other studies have found varia-
tions of a three-factor structure to have the best model
fit for the HADS as indicated in Table 5. The differences
in factor structure found across studies might be ex-
plained by different methodology such as data extraction
method, model fit criteria, translation or type of patients
included.
When considering the content of the three factors sug-
gested by Friedman et al. [44]; psychomotor agitation
(item 1, 7, 11), psychic anxiety (item 3, 5, 9, 13) and de-
pression (item 2, 4, 6, 8, 10, 12, 14), the division of items
from the original HADS-A into two factors can make
sense as relating to two different dimensions of anxiety
disorder. The items in the psychomotor agitation sub-
scale relate to physical feelings of restlessness and agita-
tion while the items in the psychic anxiety subscale
relate to emotional representation of anxiety with worry-
ing and nervous thoughts. Agitation is, however, also a
common symptom among patients with depressive dis-
orders and can occur as a side effect of antidepressant
medication [47].
The interrelatedness between symptoms of anxiety
and depression is further evident in the high correla-
tions between HADS-A and HADS-D. This did not
change when looking at the three-factor structure
instead. It has previously been argued that a high
Table 3 Item and score statistics
Score distribution, n (%)
Mean (SD) 0 1 2 3 Missing
HADS-A
n = 12,806
5.79
(4.19)
1. I feel tense or ‘wound up’* 1.05
(0.83)
3471
(25.8)
6413
(47.6)
2662
(19.8)
745
(5.5)
172
(1.3)
3. I get a sort of frightened feeling as if something awful is about to happen* 1.09
(0.90)
4050
(30.1)
4702
(34.9)
3754
(27.9)
361
(5.7)
196
(1.5)
5. Worrying thoughts go through my mind* 0.90
(0.89)
5189
(38.5)
5027
(37.3)
2244
(16.7)
790
(5.9)
213
(1.6)
7. I can sit at ease and feel relaxed 0.73
(0.73)
5673
(42.1)
5746
(42.7)
1721
(12.8)
156
(1.2)
167
(1.2)
9. I get a sort of frightened feeling like ‘butterflies’ in the stomach 0.62
(0.72)
6596
(50.0)
5354
(39.8)
1009
(7.5)
304
(2.3)
200
(1.5)
11. I feel restless as I have to be on the move* 0.88
(0.81)
4874
(36.2)
5549
(41.2)
2444
(18.2)
413
(3.1)
183
(1.4)
13. I get sudden feelings of panic* 0.52
(0.69)
7691
(57.1)
4355
(32.4)
1035
(7.7)
163
(1.2)
219
(1.6)
HADS-D
n = 12,806
4.29
(3.65)
2. I still enjoy the things I used to enjoy 0.72
(0.78)
6080
(41.2)
5332
(39.6)
1428
(10.6)
433
(3.2)
190
(1.4)
4. I can laugh and see the funny side of things 0.37
(0.64)
9403
(69.8)
2991
(22.2)
766
(5.7)
131
(1.0)
172
(1.3)
6. I feel cheerful* 0.51
(0.65)
8309
(61.7)
3358
(24.9)
1417
(10.5)
209
(1.6)
170
(1.3)
8. I feel as if I am slowed down* 1.40
(0.93)
2078
(15.4)
5912
(43.9)
3177
(23.6)
2122
(15.8)
174
(1.3)
10. I have lost interest in my appearance* 0.43
(0.69)
8983
(66.7)
3076
(22.9)
1080
(8.0)
138
(1.0)
186
(1.4)
12. I look forward with enjoyment to things 0.52
(0.74)
8119
(60.3)
3593
(26.7)
1313
(9.8)
225
(1.7)
213
(1.6)
14. I can enjoy a good book or radio or TV program 0.37
(0.69)
9654
(71.7)
2608
(19.4)
705
(5.2)
289
(2.2)
207
(1.5)
Each item is scored on a scale of 0–3 with each subscale ranging from 0 to 21. For six items higher scores indicate a worse response. The eight items highlighted
with * are reverse scored. These are reversed when summing the subscales
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Table 4 Exploratory factor analysis - rotated factor matrixa
Factor
1 2
Item 9. I get a sort of frightened feeling like ‘butterflies’ in the stomach 0.81
Item 3. I get a sort of frightened feeling as if something awful is about to happen 0.80
Item 5. Worrying thoughts go through my mind 0.69
Item 13. I get sudden feelings of panic 0.71
Item 1. I feel tense or ‘wound up’ 0.60
Item 7. I can sit at ease and feel relaxed 0.41 0.36
Item 11. I feel restless as I have to be on the move 0.46
Item 12. I look forward with enjoyment to things 0.79
Item 6. I feel cheerful 0.67
Item 2. I still enjoy the things I used to enjoy 0.72
Item 4. I can laugh and see the funny side of things 0.62
Item 8. I feel as if I am slowed down 0.54
Item 10. I have lost interest in my appearance 0.55
Item 14. I can enjoy a good book or radio or TV program 0.45
Cumulative % of variance explained 45.22 53.99
Eigenvalue 6.33 1.23
aExploratory factor analyses using principal axis extraction based in eigenvalues
greater than 1, Oblimin rotation and cut-off point of 0.30
Loadings> 0.40 in bold
Table 5 Fit indices for confirmatory factor analyses of factor structures proposed in previous studies
RMSEA
Models Number of factors Sub scale content RMSEA 90% CI p-value CFI TLI
Zigmond and Snaith 1983 [5] 2 HADS-A:
1,3,5,7,9,11,13
HADS-D:
2,4,6,8,10,12,14
0.071 0.069;0.072 < 0.001 0.973 0.968
Dunbar et al. 2000 [43] 3 Negative affect:
1,5,7,11
Autonomic anxiety:
3,9,13
Depression:
2,4,6,8,10,12,14
0.061 0.059;0.062 < 0.001 0.981 0.976
Friedman et al. 2001 [44] 3 Psychomotor agitation:
1,7,11
Psychic anxiety:
3,5,9,13
Depression:
2,4,6,8,10,12,14
0.060 0.058;0.061 < 0.001 0.981 0.977
Caci et al. 2003 [42] 3 Anxiety:
1,3,5,9,13
Depression:
2,4,6,8,10,12
Restlessness:
7,11,14
0.064 0.062;0.065 < 0.001 0.979 0.974
Kaur et al. 2015 [15] 3 Anxiety:
1,3,5,7,9,11,13
Anhedonia:
2,4,6,14
Psychomotor retardation:
8,10,12
0.069 0.068;0.071 < 0.001 0.975 0.969
Cosco et al. 2012 [21] 1 1,2,3,4,5,6,7,9,10,11,12,13 0.111 0.109;0.113 < 0.001 0.945 0.932
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correlation between anxiety and depression is to be ex-
pected, not because of common symptoms but because
it is possible that anxiety can lead to depression and
that depression can lead to anxiety. It is also possible
that the two disorders result from a common cause.
The causality of this relationship cannot, however, be
determined from cross-sectional data [48].
In the EFA item 7 was found to load almost equally on
both factors. This has been found in previous studies as
well [13]. Item 7 reads ‘I can sit at ease and feel relaxed’;
this may reflect aspects of both anxiety and depression.
Eight items in the HADS are reversely scored. This is
a recommended method to avoid acquiescence bias
which is the tendency for respondents of a survey to
agree with statements regardless of their content. How-
ever, research suggests that individual differences in
response styles can systematically affect the factor
structure [49]. The uncertainty of the factor structure
of the HADS is not necessarily a reason to discard the
instrument, but rather to be clear on the purpose of
using the scale. The two-factor structure may prove
useful as a simple indication of either anxiety or de-
pression. The possible presence of a third factor indi-
cates that the scale may provide more refined results
regarding different aspects of anxiety, rather than just
an indication of generalized anxiety. Because the results
regarding factor structure were not clear, the two-
factor structure originally proposed was used in the
remaining analyses for the paper.
There were floor effects on all items, which may indi-
cate that the number of extreme response categories is
not sufficient. As the HADS was developed to detect in-
dications of a mood disorder, which is not present in the
majority of the population, even a population with se-
vere illness, it is not surprising that there are floor ef-
fects. Item 8 also showed a ceiling effect. The item reads
‘I feel as if I am slowed down’. In a population of elderly,
severely ill patients just discharged, it is not surprising
that this feeling would be prevalent. This item is suscep-
tible to influence from either age or disease which is a
bias in terms of validity as an indicator of mood.
The analyses of DIF indicated that there could be po-
tential problems with DIF for several items. However,
Fig. 1 Diagram from the confirmatory factor analysis presenting the
model with the best fit. Standardized loadings (SE). PAn = psychic
anxiety; Dep = depression; PAg = psychomotor agitation
Table 6 HADS scores in relation to SF-12 and HeartQoL scores
HADS-A
< 8 ≥8
HADS-D n (%) 8211 (64.1) 553 (4.3)
< 8 MCS, mean (SD) 53.03 (7.96) 42.96 (8.63)
PCS, mean (SD) 44.13 (10.43) 34.11 (9.07)
HeartQoL emotional, mean (SD) 2.50 (0.56) 1.56 (0.68)
HeartQoL physical, mean (SD) 1.83 (0.83) 1.47 (0.81)
n (%) 2147 (16.8) 1895 (14.8)
≥8 MCS, mean (SD) 42.01 (9.16) 34.11 (9.07)
PCS, mean (SD) 33.44 (9.93) 35.53 (10.03)
HeartQoL emotional, mean (SD) 1.92 (0.70) 1.04 (0.69)
HeartQoL physical, mean (SD) 1.02 (0.71) 0.95 (0.70)
HADS Hospital Anxiety and Depression Scale; SF-12 = Short Form 12; HADS-A = Hospital Anxiety and Depression Scale – Anxiety; HADS-D = Hospital Anxiety and
Depression Scale – Depression; MCS =Mental Component Scale; PCS = Physical Component Scale; SD = Standard deviation
The cut-off of 8 is used as an indicator of possible mood disorder
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Table 7 Differential item functioning tested for gender
OR (95% CI)a
for item
responses
1, 2 and 3
Overall
p-value
Significant interaction
between gender and
sub scale
Nagelkerke’s R2
Step 1
Nagelkerke’s R2
Step 2
Nagelkerke’s R2
Step 3
DIF R2 b
HADS-A
Item 1. I feel tense or ‘wound up’ X 0.6712 0.6714 0.6717 0.0005
Item 3. I get a sort of frightened feeling
as if something awful is about to
happen
1: 0.948
(0.782;1.149)
2: 0.801
(0.719;0.892)
3: 0.916
(0.820;1.023)
0.0007 0.6287 0.6293 0.6295 0.0008
Item 5. Worrying thoughts go through
my mind
X 0.6924 0.6930 0.6932 0.0008
Item 7. I can sit at ease and feel relaxed X 0.6008 0.6011 0.6018 0.0010
Item 9. I get a sort of frightened feeling
like ‘butterflies’ in the stomach
X 0.6718 0.6726 0.6730 0.0012
Item 11. I feel restless as I have to be on
the move
1:1.670
(1.315;2.122)
2: 1.385
(1.240;1.545)
3: 1.423
(1.289;1.571)
<.0001 0.4746 0.4785 0.4788 0.0042
Item 13. I get sudden feelings of panic 1: 0.667
(0.462;0.963)
2: 0.712
(0.600;0.845)
3: 0.781
(0.703;0.868)
<.0001 0.6291 0.6307 0.6308 0.0017
HADS-D
Item 2. I still enjoy the things I used
to enjoy
X 0.6107 0.6112 0.6116 0.0009
Item 4. I can laugh and see the funny
side of things
1: 0.865
(0.587;1.274)
2: 0.917
(0.765;1.099)
3: 0.805
(0.719;0.902)
0.0025 0.5739 0.5747 0.5747 0.0008
Item 6. I feel cheerful 1: 1.079
(0.750;1.551)
2: 1.089
(0.937;1.266)
3: 1.071
(0.956;1.200)
0.5055 0.6381 0.6381 0.6385 0.0004
Item 8. I feel as if I am slowed down X 0.5660 0.5676 0.5684 0.0024
Item 10. I have lost interest in my
appearance
1: 0.813
(0.561;1.177)
2: 1.050
(0.905;1.218)
3: 0.956
(0.866;1.054)
0.3345 0.4235 0.4237 0.4239 0.0003
Item 12. I look forward with enjoyment
to things
X 0.6136 0.6142 0.6143 0.0007
Item 14. I can enjoy a good book or
radio or TV program
1: 2.132
(1.558;2.918)
2: 1.612
(1.361;1.909)
3: 1.431
(1.289;1.587)
<.0001 0.3805 0.3853 0.3855 0.0050
a Partial proportional odds model with item response as dependent variable and gender and subscale as independent variable. Men are reference
Step 1: Partial proportional odds model with item response as dependent variable including subscale
Step 2: Partial proportional odds model with item response as dependent variable including subscale and gender
Step 2: Partial proportional odds model with item response as dependent variable including subscale, gender and an interaction between the two
b Indication of both uniform and non-uniform DIF
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because of the risk of finding statistically significant re-
sults of minimal clinical importance in this large popula-
tion, changes in Nagelkerke’s R2 between models were
given priority. These indicated no noticeable DIF for any
items. The presence of DIF for gender has been explored
in previous studies [22–24, 50], but only one study
found substantial DIF for item 14, with men being more
likely to endorse this item [22].
When considering the usefulness of the HADS in clin-
ical practice it should also be noted that HADS has been
shown to predict morbidity and mortality in this patient
population and similar patient populations [3, 4, 51].
Limitations of the study
There is no description of the process of how the HADS
was translated into Danish from the questionnaire
owner, so it is not clear whether the translation has
followed the recommended steps to ensure cross-
cultural validity [45]. The current analyses are, in fact,
the first specific investigation of the psychometric prop-
erties of the Danish language version of HADS. For the
current study, we evaluated the TVI for each item and
the total scale with satisfactory results. Items 3 and 11
(both in HADS-A) received the lowest rating (60%).
Newer methods for exploring internal consistency
exist, e.g. the use of McDonalds omega. However, for
consistency with the methods chosen throughout this
paper and for comparison with other HADS validation
studies we chose to include Cronbach’s alpha.
The large sample size in this study is an advantage be-
cause of statistical power and because it allows a hetero-
geneous sample. There is, however, a risk of finding
statistically significant results of minimal clinical import-
ance. Therefore, we have not only looked at p-values to
determine validity, but rather measures of strength of
correlation, internal consistency and Nagelkerke’s R2 for
analyses of DIF.
The response rate was 51%, which is to be expected in
a population of severely ill patients on the day of hos-
pital discharge. This may raise concerns about represen-
tativeness, however, the proportions of patients in the
diagnostic sub-groups were similar to that of the entire
eligible population, and responders and non-responders
were comparable in terms of their demographic and
clinical profiles, suggesting a representative sample [2].
We did, however, find a higher mortality rate in non-
responders compared to responders [4].
In the present study we used a single question on anx-
iety and depression to measure convergent validity.
However, the two questions were highly correlated. In-
cluding more comprehensive instruments to measure
anxiety and depression would have been optimal to
examine convergent validity. These were, however, not
available in the data.
Conclusions
The findings of this study supported the validity and re-
liability of the HADS in a sample of Danish patients with
cardiac disease. EFA supported the original two-factor
structure of the scale, while CFA supported a three-
factor structure consisting of the original depression
subscale and two anxiety subscales; psychomotor agita-
tion and psychic anxiety. The hypotheses regarding con-
vergent validity were confirmed, but those regarding
divergent validity were not confirmed for HADS-D.
Internal consistency was good with a Cronbach’s alpha
of 0.87 for HADS-A and 0.82 for HADS-D. There were
no indications of noticeable DIF by gender for any
items.
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